Bruker and Evosep Announce Major Progress in Unbiased, Quantitative True Single-cell Proteomics

Breakthrough new paper by Mann-group demonstrates that unbiased, quantitative true single-cell proteomics can address important questions in cell biology and single-cell pathobiology Measured single-cell protein and RNA levels are very different, which implies distinct RNA and protein abundance regulation mechanisms. Protein measurements thus yield complementary quantitative biology information. Results also imply stable cellular core proteomes... Read more

Thermo Fisher Scientific Announces Collaboration to Revolutionize Profiling of Large Plasma Sample Cohorts in Protein-based Clinical Research Studies

Thermo Fisher Scientific Announces Collaboration to Revolutionize Profiling of Large Plasma Sample Cohorts in Protein-based Clinical Research Studies ATLANTA, June 3, 2019 /PRNewswire/ — ASMS 2019 – Thermo Fisher Scientific, the world leader in serving science, and Evosep, a leading provider of sample preparation technologies for protein-based clinical research, have entered into a collaboration to develop... Read more

Bruker and Evosep Announce New Integrated Clinical Research Proteomics Solution to Quantify Over a Thousand Proteins in Five Minutes

MINNEAPOLIS, March 12, 2018 /PRNewswire/ — At the 2018 US HUPO Conference, Bruker (NASDAQ: BRKR) and Evosep announce that they have executed a co-development and co-marketing agreement for the Evosep One chromatography system to work seamlessly with Bruker’s timsTOF Pro ultra-high resolution quadrupole time of flight mass spectrometer.  The timsTOF Pro is powered by TIMS... Read more